These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25294587)

  • 1. Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease.
    Bogari H; Patanwala AE; Cosgrove R; Katz M
    Thromb Res; 2014 Dec; 134(6):1220-3. PubMed ID: 25294587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
    Reichert JA; Hlavinka PF; Stolzfus JC
    Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
    Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
    Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
    Barclay SM; Jeffres MN; Nguyen K; Nguyen T
    Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proportion and prevention of venous thromboembolism among hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Beijing].
    Liang LR; Zhang Z; Wang H; Xu ZY; Qian XS; Zhang ZQ; Chen J; Zhang FZ; Yang YH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(30):2337-40. PubMed ID: 24300197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
    Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
    Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
    J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center.
    Fritz MK; Kincaid SE; Sargent CG; Green AH; Davis GA
    J Thromb Thrombolysis; 2021 Jan; 51(1):67-73. PubMed ID: 32447745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
    Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
    J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.
    Smith CB; Hurdle AC; Kemp LO; Sands C; Twilla JD
    J Hosp Med; 2013 Oct; 8(10):569-73. PubMed ID: 24101541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life use of thromboprophylaxis in patients hospitalized for pulmonary disorders: A single-center retrospective study.
    Łukaszuk RF; Plens K; Undas A
    Adv Clin Exp Med; 2018 Feb; 27(2):237-243. PubMed ID: 29521068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
    Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
    J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
    Nendaz M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Jäger K; Righini M; Bounameaux H
    Thromb Haemost; 2014 Mar; 111(3):531-8. PubMed ID: 24226257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.
    Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL
    J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprophylaxis for venous thromboembolism in otolaryngology.
    Bahl V; Shuman AG; Hu HM; Jackson CR; Pannucci CJ; Alaniz C; Chepeha DB; Bradford CR
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):999-1005. PubMed ID: 25275427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.
    Zhou H; Hu Y; Li X; Wang L; Wang M; Xiao J; Yi Q
    J Atheroscler Thromb; 2018 Nov; 25(11):1091-1104. PubMed ID: 29540637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments.
    Vardi M; Ghanem-Zoubi NO; Zidan R; Yurin V; Bitterman H
    J Thromb Haemost; 2013 Mar; 11(3):467-73. PubMed ID: 23279085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.